The British Society for Rheumatology biologics register: 6 years on

被引：53

作者：

Hyrich, K. L. ^{[1
]}

Watson, K. D. ^{[1
]}

Isenberg, D. A. ^{[2
]}

Symmons, D. P. M. ^{[1
]}

机构：

[1] Univ Manchester, ARC Epidemiol Unit, Manchester M13 9PT, Lancs, England

[2] UCL, Div Med, Ctr Rheumatol Res, London, England

来源：

RHEUMATOLOGY | 2008年 / 47卷 / 10期

关键词：

D O I：

10.1093/rheumatology/ken242

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1441 / 1443

页数：3

共 14 条

[1]

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register [J].

Dixon, W. G. ;

Watson, K. D. ;

Lunt, M. ;

Silman, A. J. ;

Hyrich, K. L. ;

Symmons, D. P. M. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2905-2912

[2]

Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies [J].

Dixon, W. G. ;

Symmons, D. P. M. ;

Lunt, M. ;

Watson, K. D. ;

Hyrich, K. L. ;

Silman, A. J. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2896-2904

[3]

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register [J].

Dixon, W. G. ;

Watson, K. ;

Lunt, M. ;

Hyrich, K. L. ;

Silman, A. J. ;

Symmons, D. P. M. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2368-2376

[4]

Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study [J].

Doran, MF ;

Crowson, CS ;

Pond, GR ;

O'Fallon, WM ;

Gabriel, SE .

ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2287-2293

[5]

Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register [J].

Hyrich, K. ;

Symmons, D. ;

Watson, K. ;

Silman, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) :895-898

[6]

Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register [J].

Hyrich, K. L. ;

Watson, K. D. ;

Silman, A. J. ;

Symmons, D. P. M. .

RHEUMATOLOGY, 2006, 45 (12) :1558-1565

[7]

Outcomes after switching from one anti-tumor necrosis factor α agent to a second anti-tumor necrosis factor α agent in patients with rheumatoid arthritis -: Results from a large UK national cohort study [J].

Hyrich, Kimme L. ;

Lunt, Mark ;

Watson, Kath D. ;

Symmons, Deborah P. M. ;

Silman, Alan J. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (01) :13-20

[8]

Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register [J].

Hyrich, Kimme L. ;

Symmons, Deborah P. M. ;

Watson, Kath D. ;

Silman, Alan J. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2701-2702

[9]

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis - Results from the British Society for Rheumatology Biologics Register [J].

Hyrich, Kimme L. ;

Symmons, Deborah P. M. ;

Watson, Kath D. ;

Silman, Alan J. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1786-1794

[10]

Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001) [J].

Ledingham, J ;

Deighton, C .

RHEUMATOLOGY, 2005, 44 (02) :157-163

← 1 2 →